NZ
Moleac Pipeline
| Drug | Indication | Phase |
|---|---|---|
| MLC901 (NeuroAiD) | Post‑stroke, Traumatic Brain Injury, Cognitive Decline | Phase 2/3 |
| MLC1501 | Post‑stroke motor recovery | Phase 2 |
| ANDROMEDA | Moderate Traumatic Brain Injury | Phase 2 |
| SAMURAI | Mild Traumatic Brain Injury – Cognitive Function | Phase 2 |
| MAESTOSO | Post‑stroke motor deficits | Phase 2 |